3825. Misbranding of methyltestosterone tablets and Sulfonamides Triplex tab-
lets. U. S. v. Lynne E. Steele (Steele Drug Store). Plea of guilty.
Fine, $200. (F. D. C. No. 32706. Sample Nos. 13776-L, 13777-L, 13780-L,
13781-L.)
INFORMATION FILED:    April 1, 1952, District of Utah, against Lynne E. Steele,
trading as the Steele Drug Store, Salt Lake City, Utah.
ALLEGED VIOLATION : On or about September 15, 18, 24, and 25, 1951, while
quantities of methyltestosterone tablets and Sulfonamides Triplex tablets were
being held for sale at the Steele Drug Store after shipment in interstate com-
merce, the defendant caused a number of tablets of such drugs to be repacked
and dispensed without physicians' prescriptions, which acts resulted in the
repackaged drugs being misbranded.
NATURE OF CHARGE: Misbranding, Sections 502 (b) (1) and (2), the repack-
aged drugs failed to bear labels containing the name and place of business of
the manufacturer, packer, or distributor, and an accurate statement of the
quantity of the contents; Section 502 (e) (1), the repackaged drugs were not
designated solely by names recognized in an official compendium and were
fabricated from two or more ingredients, and they failed to bear labels con-
taining the common or usual name of each active ingredient; Section 502 (f)
(1), the repackaged drugs failed to bear labeling containing adequate direc-
tions for use; and, Section 502 (f) (2), the repackaged Sulfonamides Triple-
tablets failed to bear labeling containing adequate warnings against use in
those pathological conditions where their use may be dangerous to health, and
against unsafe dosage and methods and duration of administration, in such
manner and form, as are necessary for the protection of users.
DISPOSITION: May 2, 1952. A plea of guilty having been entered, the court
imposed a fine of $200.